$CLS

MIONIS ROBERT sold $3.5M of CLS (indirect holdings)

MIONIS ROBERT (Chief Executive Officer) sold 9,543 indirectly-held shares of CELESTICA INC (CLS) at an average of $367.49 ($360.47–$374.49, $3.51M total) across 11 trades on 2026-07-31 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MIONIS ROBERT
Published Aug 3, 2026, 10:19 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 10:21 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CLS
Neutral
high confidence
Mentioned
$CLS
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CLSNeutralLow
01

Why it matters

Traders may monitor insider activity as a sentiment input, but 10b5-1 sales are generally less informative about near-term fundamentals. Without accompanying guidance, contract, or earnings news, the impact is likely limited.

02

Market read

A scheduled CEO 10b5-1 sale of about $3.5M of CLS shares is disclosed, offering limited incremental trading signal absent other catalysts.

03

What to watch

The filing does not clarify whether other insiders sold/bought around the same window, nor does it provide context on total insider ownership changes beyond the post-transaction figure.

Relevance 5/10Novelty 5/10Timing: filed 2026-08-03, transaction dated 2026-07-31

Background

The article is an SEC Form 4 insider transaction disclosure for Celestica (CLS) by CEO Mionis Robert, marked as an indirect open-market sale under a 10b5-1 plan.

Company-level read

Ticker impact

$CLSNeutralHigh confidence
Context

Celestica CEO Mionis Robert sold $3.51M of CLS shares via a 10b5-1 plan on 2026-07-31, disclosing indirect holdings after sale.

Expected impact

Low likelihood of a sustained price move; any reaction is likely short-lived unless paired with other catalysts.

Evidence & confidence

The filing is a Form 4 insider transaction with a pre-arranged 10b5-1 plan, and the article contains no new operational, financial, or regulatory developments.

Market effects

Minimal, as this is company-specific insider selling with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • Celestica Inc.

    Subject of the Form 4 insider transaction disclosure (CLS).

  • Mionis Robert

    CEO and officer/director who sold shares under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CLSMed

Canada Trade War: What It Means for Electronics Manufacturing · EMSNow

Canada and the US imposed tariffs on each other's exports, including electronics, with no expiry date. Canadian electronics exports are heavily dependent on the US, making the sector vulnerable. Celestica and other EMS providers may relocate production to mitigate costs. Provincial and federal governments are offering support programs. Investors should watch Q3 earnings for affected companies and the impact of Canada's retaliatory tariffs on September 8.

$CLSMedAI 8/10

Celestica Stock Falls 2.63%: Why TSX:CLS Is in Focus After AI Infrastructure Boom, $20.5 Billion Revenue Outlook and New 2027 Growth Catalysts

Celestica Inc. (TSX:CLS) shares fell 2.63% on Aug. 14, 2026 despite strong Q2 results and raised outlook. Q2 revenue rose about 62% to US$4.70B and adjusted EPS to US$2.54. 2026 revenue guidance was lifted to about US$20.5B, adjusted EPS to US$11.30, and FCF to US$600M, with 2027 growth expected to accelerate on AI infrastructure demand.